biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by Sniper007on Oct 25, 2013 7:28pm

182 Views

Post# 21850673

RE:just another bullspit biotech.....

Oily,
For what reason(s) did you buy BTI? Has the reason(s) changed?
Are you suggesting BTI has lied to you or that the test results from reputable sources are a farce? Shyzer? Really?
You should sell your stock now before it gets any lower. Don't be foolish and wait until it's too late! Sell now!
Stick to the oilpatch.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario